chalcone has been researched along with Malaria in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Batovska, DI; Bhalla, A; Markova, N; Medhi, B; Radotra, BD; Sehgal, R; Sinha, S | 1 |
| Cheng, P; Gong, M; Huang, X; Wang, X; Yang, L | 1 |
| Alsulami, H; Lekkala, R; Qin, HL; Rakesh, KP; Zhang, ZW | 1 |
| Batovska, DI; Medhi, B; Prakash, A; Sehgal, A; Sehgal, R; Sinha, S | 1 |
| Kumar, A; Kumar, D; Kumar, M; Singh, SK | 1 |
| Ferreira, EI; Giarolla, J | 1 |
| Dominguez, JN; Gamboa de Dominguez, N; Gut, J; Leon, C; Rodrigues, J; Rosenthal, PJ | 1 |
| Gauniyal, HM; Kumar, M; Modukuri, RK; Puri, SK; Sashidhara, KV; Saxena, JK; Singh, SV; Soni, A; Srivastava, K; Srivastava, RK | 1 |
| Go, ML | 1 |
| Go, ML; Kirk, K; Liu, M; Rosenthal, PJ; Saliba, KJ; Wilairat, P | 1 |
| Cartier, D; Charneau, S; Florent, L; Labia, R; Le Guillou, R; Potier, P; Schrevel, J; Valla, A; Valla, B | 1 |
| Chen, M; Christensen, SB; Hviid, L; Kharazmi, A; Theander, TG; Zhai, L | 1 |
| Brøgger Christensen, S; Chen, M; Davidsen, J; Frøkjaer, S; Kharazmi, A; Rasmussen, MH; Steffansen, B; Theander, TG; Zhai, L | 1 |
| Chandra, S; Ram, VJ; Saxena, AS; Srivastava, S | 1 |
| Charris, JE; Domínguez, JN; Gamboa de Domínguez, N; Lobo, G; Moreno, MM; Olson, J; Riggione, F; Rosenthal, PJ; Sanchez, E | 1 |
| Go, ML; Liu, M; Wilairat, P | 1 |
| Prescott, B | 1 |
5 review(s) available for chalcone and Malaria
| Article | Year |
|---|---|
Chalcone hybrids and their antimalarial activity.
Topics: Animals; Antimalarials; Chalcone; Chemistry, Pharmaceutical; Drug Resistance; Humans; Malaria; Parasitic Sensitivity Tests; Plasmodium; Structure-Activity Relationship | 2020 |
Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review.
Topics: Animals; Antimalarials; Chalcone; Dose-Response Relationship, Drug; Drug Discovery; Humans; Malaria; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2020 |
Chalcone and curcumin derivatives: a way ahead for malarial treatment.
Topics: Antimalarials; Chalcone; Curcumin; Drug Resistance; Histone Acetyltransferases; Humans; Malaria; Plasmodium; Structure-Activity Relationship | 2013 |
Drug design for neglected disease in Brazil.
Topics: Animals; Antiprotozoal Agents; Antitubercular Agents; Brazil; Chagas Disease; Chalcone; Drug Design; Humans; Leishmaniasis; Malaria; Mycobacterium tuberculosis; Neglected Diseases; Parasites; Tuberculosis | 2015 |
Novel antiplasmodial agents.
Topics: Alkaloids; Alkyl and Aryl Transferases; Animals; Antimalarials; Chalcone; Databases as Topic; Enzyme Inhibitors; Farnesyltranstransferase; Inhibitory Concentration 50; Malaria; Models, Chemical; Naphthoquinones; Peptides; Phenothiazines; Plasmodium; Protease Inhibitors; Quaternary Ammonium Compounds; Terpenes; Xanthones | 2003 |
12 other study(ies) available for chalcone and Malaria
| Article | Year |
|---|---|
Antimalarial and immunomodulatory potential of chalcone derivatives in experimental model of malaria.
Topics: Animals; Antimalarials; Chalcone; Chalcones; Humans; Immunity; Malaria; Mice; Mice, Inbred BALB C; Models, Theoretical; Parasitemia; Plasmodium berghei | 2022 |
Pharmacokinetic evaluation of Chalcone derivatives with antimalarial activity in New Zealand White Rabbits.
Topics: Animals; Antimalarials; Chalcone; Chalcones; Malaria; Plasmodium; Plasmodium falciparum; Rabbits | 2021 |
Synthesis of chlorovinyl sulfones as structural analogs of chalcones and their antiplasmodial activities.
Topics: Animals; Antimalarials; Chalcone; Hemeproteins; Hemoglobins; Humans; Hydrolysis; Malaria; Mice; Plasmodium berghei; Plasmodium falciparum; Sulfones | 2009 |
Antiplasmodial activity of novel keto-enamine chalcone-chloroquine based hybrid pharmacophores.
Topics: Administration, Oral; Animals; Antimalarials; Biphenyl Compounds; Cell Line; Chalcone; Chlorocebus aethiops; Chloroquine; Chloroquinolinols; Cyclohexenes; Drug Resistance; Imidazoles; Malaria; Mice; Plasmodium falciparum; Plasmodium yoelii; Vero Cells | 2012 |
Antiplasmodial chalcones inhibit sorbitol-induced hemolysis of Plasmodium falciparum-infected erythrocytes.
Topics: Animals; Antimalarials; Carcinoma, Squamous Cell; Cell Line, Tumor; Chalcone; Chemical Phenomena; Chemistry, Physical; Erythrocyte Membrane; Erythrocytes; Hemolysis; Humans; Malaria; Plasmodium falciparum; Sorbitol; Structure-Activity Relationship | 2004 |
New syntheses and potential antimalarial activities of new 'retinoid-like chalcones'.
Topics: Animals; Antimalarials; Chalcone; Erythrocytes; Humans; Inhibitory Concentration 50; Malaria; Parasitemia; Plasmodium falciparum; Retinoids | 2006 |
Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection.
Topics: Animals; Antimalarials; Chalcone; Chalcones; Chloroquine; Drug Resistance; Female; Hypoxanthines; Malaria; Mice; Mice, Inbred BALB C; Plasmodium falciparum; Plasmodium yoelii | 1994 |
The novel oxygenated chalcone, 2,4-dimethoxy-4'-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivo.
Topics: Animals; Antimalarials; Chalcone; Chalcones; Drug Resistance; Female; Humans; Malaria; Male; Mice; Mice, Inbred BALB C; Monocytes; Neutrophils; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Rats; Rats, Wistar | 1997 |
Oxygenated chalcones and bischalcones as potential antimalarial agents.
Topics: Animals; Antimalarials; Chalcone; Chloroquine; Drug Design; Drug Resistance; Malaria; Male; Mice; Molecular Structure; Plasmodium berghei | 2000 |
Synthesis of quinolinyl chalcones and evaluation of their antimalarial activity.
Topics: Animals; Antimalarials; Chalcone; Drug Design; Drug Evaluation, Preclinical; Endopeptidases; Gas Chromatography-Mass Spectrometry; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Malaria; Male; Mice; Mice, Inbred BALB C; Plasmodium berghei; Plasmodium falciparum; Quinolones; Structure-Activity Relationship | 2001 |
Antimalarial alkoxylated and hydroxylated chalcones [corrected]: structure-activity relationship analysis.
Topics: Animals; Anisoles; Antimalarials; Chalcone; Chromatography, High Pressure Liquid; Hydrophobic and Hydrophilic Interactions; Hydroxylation; Malaria; Male; Mice; Models, Molecular; Multivariate Analysis; Plasmodium berghei; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Resorcinols; Styrenes | 2001 |
Thiosemicarbazones and hydrazones of alpha-methylchalkone as potential chemotherapeutic agents.
Topics: Animals; Antimalarials; Antineoplastic Agents; Carcinoma 256, Walker; Chalcone; Chloroquine; Drug Evaluation, Preclinical; Hydrazones; Leukemia L1210; Malaria; Mice; Mice, Inbred DBA; Plasmodium berghei; Propiophenones; Thiosemicarbazones | 1975 |